P-396 Characterization and Management of Ocular Events in Patients (Pts) Treated With Belantamab Mafodotin (Belamaf) Plus Bortezomib and Dexamethasone (BVd) in the DREAMM-7 Study

Article2024

P-413 Characterization and Management of Ocular Events in Patients Treated With Belantamab Mafodotin Plus Pomalidomide and Dexamethasone in the DREAMM-8 Study

Hang Quach, Meletios A Dimopoulos, Meral Beksaç, Luděk Pour, Sosana Delimpasi, Vladimir Vorobyev, Ivan Špıčka, Jakub Radocha, Paweł Robak, Kihyun Kım, Michèle Cavo, Kazuhito Suzuki, Kristin Morris, Farrah Pompilus, Jodie Wilkes, Amy Philips-Jones, Margaret Polinkovsky, Xiaoou Zhou, Giulia Fulci, Neal Sule, Brandon E. Kremer, Joanna Opalińska, María-Victoria Mateos Manteca, Suzanne Trudel

Article2025

Baseline ocular conditions and risk of ocular events in patients (pts) with relapsed/refractory multiple myeloma (RRMM) from the DREAMM-7 and DREAMM-8 trials of belantamab mafodotin (belamaf).

Meral Beksac, Hang Quach, Vânia Hungria, Luděk Pour, Kihyun Kım, Sergey Voloshin, Hanlon Sia, Esther González, Chang‐Ki Min, Marcelo Pitombeira de Lacerda, Anna Sureda, Ivan Špıčka, Marek Hus, Vera Zherebtsova, Margaret Polinkovsky, Sybil Varghese, Shing Yip Lee, Elisabet E. Manasanch, Paweł Robak, Meletios A Dimopoulos

Article2024

P-395 Updated Results From DREAMM-3, a Phase 3 Study of Belantamab Mafodotin (Belamaf) Versus Pomalidomide Plus Dexamethasone in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM)

Vânia Hungria, Katja Weisel, Atanas Radinoff, Sosana Delimpasi, Gábor Mikala, Tamás Masszi, Jian Li, Marcelo Capra, Ângelo Maiolino, Vasiliki Pappa, Dominik Chraniuk, Iurii Osipov, Xavier Leleu, Michael Löw, Fotini M. Kouri, John Liboon, Chris Brawley, Eric Lewis, Gabriela Tubel, Mary Li, Astrid McKeown, Sumita Roy–Ghanta,

Article2025

Characterization of Infections in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With Belantamab Mafodotin (Belamaf)–Based Regimens From the DREAMM-7 and DREAMM-8 Trials

Paweł Robak, Vânia Hungria, Luděk Pour, Kihyun Kım, Sergey Voloshin, Hanlon Sia, Esther González García, Chang‐Ki Min, Marcelo Pitombeira de Lacerda, Anna Sureda Balarí, Ivan Špıčka, Sosana Delimpasi, Marek Hus, Vera Zherebtsova, Christopher Wård, P. Joy Ho, Roman Hájek, Sebastian Grosicki, Kristin Morris, Maureen Nichols, Benga Kazeem, Elisabet E. Manasanch,

Article2020

DREAMM-7: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin (Belamaf) with Bortezomib, and Dexamethasone (B-Vd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Robert M. Rifkin, Kevin Boyd, Sebastian Grosicki, Kihyun Kım, Francesco Di Raimondo, Meletios A Dimopoulos, Katja Weisel, Bertrand Arnulf, Roman Hájek, Vânia T. M. Hungria, Andrew Spencer, Randy Davis, Antonio Riccio, Chanbin Kim, Jodie Wilkes, Ruth Z. Rutledge, Mala K. Talekar, Brandon E. Kremer, Ira Gupta, María‐Victoria Mateos

Discussion(0)

Related publications